|
Market Cap (5-Jun) $61,568,592 (1,444th) |
Close (30-Jun) $0.076 |
Volume (30-Jun) 120,981 |
Shortsold (26-May) 11,577 (0.00%) (629th) |
|
52w High $0.425 |
52w Low $0.056 |
P/E - |
EPS -0.02 |
ATX released this announcement to the ASX on 16 February 2021, 16:20. The announcement is not marked as price sensitive, and is 16 page(s) in length and 417.1kb in size.
You can view all announcements from ATX and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATX was 0.017% short sold according to ASIC data. It was ranked the 537th most shorted stock on the ASX. It remains ranked 629th as of the latest reported data (26 May 2026).
| Other Recent Announcements from ATX | |
|---|---|
| AMP945 International Nonproprietary Name Narmafotinib | 21 June 2023, 8:34 |
| Amplia AGM to be held Thursday 24 August 2023 | 19 June 2023, 17:34 |
| Key to Corporate Governance Disclosures | 31 May 2023, 8:14 |
| Appendix 2A - Exercise of Options | 16 February 2021, 16:20 |
| Investor Update - February 2021 | 11 February 2021, 9:41 |
| Quarterly Activities and Cashflow Reports - Dec 2020 Qtr | 28 January 2021, 9:59 |
| Appendix 2A - Exercise of Options | 11 January 2021, 13:21 |
You must be logged in to post a reply.
Amplia Therapeutics 